FDA approves first IDH-targeted glioma drug

Nature Biotechnology, Published online: 13 September 2src24; doi:1src.1src38/s41587-src24-src24src8-8FDA approves first IDH-targeted glioma drug…
Read More

About Author

Yuri Antes

See author's posts

FDA approves first IDH-targeted glioma drug

About Author

Yuri Antes

Adjuvant Atezolizumab Plus Bevacizumab Strike Out in HCC

Untreated Brain Aneurysms Raise Mental Illness Risk

Taking on Inequities in Pediatric Respiratory Care

NHS Trust to evaluate AI software for prostate cancer diagnosis

FlyPharma Europe, Vienna – October 2024 conference

Controversial Hungarian Gets EU Health Portfolio Nomination

EHR Nudges and Primary Care Outcomes

Taking on Inequities in Pediatric Respiratory Care

Nitrile Gloves Market Overview: Global Size, Share, and Future Outlook 2024-2032

Sounds great – HCA milestone for PharmaTimes Communications Awards

Glasgow scientists develop first bone marrow model to support human stem cells

Study finds pain gene affects success of chronic pain medicine in women

Novel JAK1 Inhibitor Reduced Treatment Failures in Active Noninfectious Uveitis

NHS Trust to evaluate AI software for prostate cancer diagnosis

FlyPharma Europe, Vienna – October 2024 conference

Controversial Hungarian Gets EU Health Portfolio Nomination

EHR Nudges and Primary Care Outcomes

Taking on Inequities in Pediatric Respiratory Care

About PhaMed

Recent News

About Author

More Stories

You may have missed

About PhaMed

Recent News

Categories